Infigratinib in upper tract urothelial carcinoma vs urothelial carcinoma of the bladder and association with comprehensive genomic profiling/cell-free DNA results Meeting Abstract

  

Authors:	Dizman, N.; Rosenberg, J. E.; Hoffman-Censits, J. H.; Quinn, D. I.; Petrylak, D. P.; Galsky, M. D.; Vaishampayan, U. N.; De Giorgi, U.; Gupta, S.; Burris, H. A.; Soifer, H. S.; Li, G.; Dambkowski, C. L.; Moran, S.; Ye, Y.; Daneshmand, S.; Bajorin, D. F.; Pal, S. K.
Abstract Title:	Infigratinib in upper tract urothelial carcinoma vs urothelial carcinoma of the bladder and association with comprehensive genomic profiling/cell-free DNA results
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	266s
Language:	English
ACCESSION:	WOS:000487345805336
DOI:	10.1200/JCO.2019.37.15_suppl.4510
PROVIDER:	wos
Notes:	Meeting Abstract: 4510 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156259